Subtype
Hepatocellular Carcinoma
CI-CAN-00002853HCC · LIHCExplore in graph →
693 active trials13 approved drugs9 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002853HCC · LIHCExplore in graph →
Clinical trials
3,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (357)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00247676 | An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer | completed | Phase 2 | 37 | PfizerINDUSTRY | 3 | Feb 18, 2010 | clinicaltrials |
| NCT00280618 | Oxaliplatin in Unresectable Hepatocellular Carcinoma | completed | Phase 2 | — | SanofiINDUSTRY | 0 | Sep 15, 2009 | clinicaltrials |
| NCT00495846 |
| completed |
| Phase 2 / Phase 3 |
| 25 |
| Federico II UniversityOTHER |
| 1 |
| Aug 17, 2009 |
| clinicaltrials |
| NCT00464919 | Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 50 | National Taiwan University HospitalOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00619541 | Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)(P2) | completed | Phase 2 | 46 | Italian Trial in Medical OncologyOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00444782 | A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma. | completed | Phase 2 | 41 | Pharmexa A/SINDUSTRY | 3 | Dec 18, 2008 | clinicaltrials |
| NCT00635323 | Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma | completed | Phase 2 | 73 | PfizerINDUSTRY | 4 | Apr 7, 2008 | clinicaltrials |
| NCT00082082 | A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma | completed | Phase 2 | — | SciClone PharmaceuticalsINDUSTRY | 1 | Jan 15, 2008 | clinicaltrials |
| NCT00464295 | Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)(HCC-CAP) | completed | Phase 2 | 15 | Aga Khan UniversityOTHER | 1 | Dec 14, 2007 | clinicaltrials |
| NCT00122876 | Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 25 | Light Sciences OncologyINDUSTRY | 3 | Dec 7, 2007 | clinicaltrials |
| NCT00534664 | Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma(TheraBionic) | completed | Phase 1 / Phase 2 | 40 | University of Sao PauloOTHER | 1 | Sep 26, 2007 | clinicaltrials |
| NCT00076609 | Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 31 | PhytoCeuticaINDUSTRY | 2 | Mar 28, 2007 | clinicaltrials |
| NCT00300521 | Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 40 | Beijing Chao Yang HospitalOTHER | 1 | Mar 9, 2006 | clinicaltrials |
| NCT00234182 | Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC | completed | Phase 1 / Phase 2 | 84 | The University of Hong KongOTHER | 0 | Dec 1, 2005 | clinicaltrials |
| NCT00154817 | A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 12 | National Taiwan University HospitalOTHER | 0 | Nov 22, 2005 | clinicaltrials |
| NCT00006332 | Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate | completed | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Feb 18, 2010source: clinicaltrials